{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:59:23Z","timestamp":1761155963527},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","gastro.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.gtc.2015.05.012","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T17:19:32Z","timestamp":1435079972000},"page":"649-660","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Treatment Strategy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma"],"prefix":"10.1016","volume":"44","author":[{"given":"Shotaro","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gtc.2015.05.012_bib1","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"214","article-title":"Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)","author":"Isaacson","year":"2008"},{"key":"10.1016\/j.gtc.2015.05.012_bib2","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/cncr.11415","article-title":"Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends","volume":"97","author":"Nakamura","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.gtc.2015.05.012_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000350051","article-title":"Gastrointestinal lymphoma: recent advances in diagnosis and treatment","volume":"87","author":"Nakamura","year":"2013","journal-title":"Digestion"},{"key":"10.1016\/j.gtc.2015.05.012_bib4","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.3748\/wjg.v19.i45.8181","article-title":"Helicobacter pylori and gastric mucosa-associated lymphoid tissue lymphoma: recent progress in pathogenesis and management","volume":"19","author":"Nakamura","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gtc.2015.05.012_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","article-title":"Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma","volume":"8","author":"Zullo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2015.05.012_bib6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gutjnl-2011-300495","article-title":"Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan","volume":"61","author":"Nakamura","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2015.05.012_bib7","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","article-title":"Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma","volume":"338","author":"Wotherspoon","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.gtc.2015.05.012_bib8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM199405053301803","article-title":"Helicobacter pylori infection and gastric lymphoma","volume":"330","author":"Parsonnet","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gtc.2015.05.012_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<3::AID-CNCR2>3.0.CO;2-P","article-title":"Helicobacter pylori and primary gastric lymphoma: a histopathologic and immunohistochemical analysis of 237 patients","volume":"79","author":"Nakamura","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.gtc.2015.05.012_bib10","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1002\/cncr.22326","article-title":"Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment","volume":"107","author":"Nakamura","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.gtc.2015.05.012_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1620\/tjem.228.223","article-title":"Eradication therapy is effective for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma","volume":"228","author":"Asano","year":"2012","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.gtc.2015.05.012_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2559.2010.03699.x","article-title":"MALT lymphoma: many roads lead to nuclear factor-\u03bab activation","volume":"58","author":"Du","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.gtc.2015.05.012_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1096-9896(199602)178:2<122::AID-PATH486>3.0.CO;2-D","article-title":"Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue","volume":"178","author":"Hussell","year":"1996","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.gtc.2015.05.012_bib14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0016-5085(99)70395-1","article-title":"Impaired T-cell regulation of B-cell growth in Helicobacter pylori-related gastric low-grade MALT lymphoma","volume":"117","author":"D'Elios","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2015.05.012_bib15","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/leu.2010.76","article-title":"B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis","volume":"24","author":"Craig","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.gtc.2015.05.012_bib16","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1182\/blood-2010-06-293266","article-title":"Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma","volume":"117","author":"Munari","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.gtc.2015.05.012_bib17","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/gut.2007.123729","article-title":"Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation","volume":"56","author":"Nakamura","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2015.05.012_bib18","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/gast.2002.33047","article-title":"T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication","volume":"122","author":"Liu","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2015.05.012_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2141.2003.04035.x","article-title":"High frequency of t(11;18) in gastric mucosa-associated lymphoid tissue lymphomas in Taiwan, including one patient with high-grade transformation","volume":"120","author":"Chuang","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.gtc.2015.05.012_bib20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/path.2466","article-title":"A20 deletion is associated with copy number gain at the TNFA\/B\/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands","volume":"217","author":"Chanudet","year":"2009","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.gtc.2015.05.012_bib21","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","article-title":"TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas","volume":"114","author":"Honma","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.gtc.2015.05.012_bib22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.2010.224949","article-title":"EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT","volume":"60","author":"Ruskon\u00e9-Fourmestraux","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2015.05.012_bib23","doi-asserted-by":"crossref","first-page":"vi144","DOI":"10.1093\/annonc\/mdt343","article-title":"Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Zucca","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gtc.2015.05.012_bib24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","article-title":"Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori","volume":"342","author":"Wotherspoon","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.gtc.2015.05.012_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/oxfordjournals.annonc.a059184","article-title":"Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma: clinicopathological study and evaluation of the prognostic factors in 143 patients","volume":"6","author":"Montalb\u00e1n","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gtc.2015.05.012_bib26","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/gut.39.4.556","article-title":"Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept","volume":"39","author":"Taal","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2015.05.012_bib27","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1053\/gast.2000.19579","article-title":"Primary gastric B-cell lymphoma: results of a prospective multicenter study","volume":"119","author":"Fischbach","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2015.05.012_bib28","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/1097-0142(19951015)76:8<1313::AID-CNCR2820760804>3.0.CO;2-1","article-title":"Primary gastric lymphoma: a clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 index","volume":"76","author":"Nakamura","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.gtc.2015.05.012_bib29","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MCG.0b013e3181b4b1ab","article-title":"Primary low-grade and high-grade gastric MALT-lymphoma presentation","volume":"44","author":"Zullo","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2015.05.012_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/oxfordjournals.annonc.a058869","article-title":"Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma","volume":"5","author":"Rohatiner","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gtc.2015.05.012_bib31","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/gut.52.6.912","article-title":"Paris staging system for primary gastrointestinal lymphomas","volume":"52","author":"Ruskon\u00e9-Fourmestraux","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2015.05.012_bib32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s10620-009-0713-8","article-title":"Double-balloon endoscopy depicts diminutive small bowel lesions in gastrointestinal lymphoma","volume":"55","author":"Matsumoto","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2015.05.012_bib33","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/gut.52.11.1656","article-title":"Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma","volume":"52","author":"Copie-Bergman","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2015.05.012_bib34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/gut.48.4.454","article-title":"Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori","volume":"48","author":"Nakamura","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2015.05.012_bib35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/hel.12033","article-title":"Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome","volume":"18","author":"Choi","year":"2013","journal-title":"Helicobacter"},{"key":"10.1016\/j.gtc.2015.05.012_bib36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3748\/wjg.v18.i7.685","article-title":"Gastric mucosa-associated lymphoid tissue lymphomas and Helicobacter pylori infection: a Colombian perspective","volume":"18","author":"Yepes","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gtc.2015.05.012_bib37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5009\/gnl.2014.8.4.408","article-title":"Treatment outcome for gastric mucosa-associated lymphoid tissue lymphoma according to Helicobacter pylori infection status: a single-center experience","volume":"8","author":"Ryu","year":"2014","journal-title":"Gut Liver"},{"key":"10.1016\/j.gtc.2015.05.012_bib38","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/gut.2005.083022","article-title":"Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas","volume":"55","author":"Raderer","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2015.05.012_bib39","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MCG.0b013e318286ff72","article-title":"Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: a systematic review","volume":"47","author":"Zullo","year":"2013","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.gtc.2015.05.012_bib40","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00277-014-2298-3","article-title":"Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up","volume":"94","author":"Raderer","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.gtc.2015.05.012_bib41","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Non-Hodgkin\u2019s lymphomas, Version 1. 2015. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nhl.pdf. Accessed February 11, 2015."},{"key":"10.1016\/j.gtc.2015.05.012_bib42","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1182\/blood-2012-01-404194","article-title":"Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas","volume":"119","author":"Kuo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.gtc.2015.05.012_bib43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1443-1661.2009.00896.x","article-title":"Predictive value of endoscopy and endoscopic ultrasonography for regression of gastric diffuse large B-cell lymphomas after Helicobacter pylori eradication","volume":"21","author":"Tari","year":"2009","journal-title":"Dig Endosc"},{"key":"10.1016\/j.gtc.2015.05.012_bib44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hon.2105","article-title":"Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone","volume":"32","author":"Aguiar-Bujanda","year":"2014","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.gtc.2015.05.012_bib45","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2005.05.660","article-title":"Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy","volume":"23","author":"L\u00e9vy","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.gtc.2015.05.012_bib46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1200\/JCO.2011.40.6272","article-title":"Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study","volume":"31","author":"Zucca","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.gtc.2015.05.012_bib47","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1002\/cncr.24605","article-title":"Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type","volume":"115","author":"Salar","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.gtc.2015.05.012_bib48","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00277-013-1865-3","article-title":"Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)","volume":"93","author":"Kiesewetter","year":"2014","journal-title":"Ann Hematol"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855315000588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855315000588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T22:23:37Z","timestamp":1652567017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855315000588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0889855315000588"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2015.05.012","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment Strategy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2015.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}